[ad_1]
HONG KONG July 24, 2018 / PRNewswire / – World Cord Blood Society (NYSE: CO) ("GCBC" or the "Society"), China's leading supplier of umbilical cord blood, laboratory tests, hematopoietic stem cell processing and stem cell storage announced today that the company filed its annual report on Form 20-F with US Securities. and Exchange Commission. The filed Form 20-F includes the audited financial statements for the fiscal year ended March 31, 2018 . Form 20-F can be accessed by visiting the US Securities and Exchange Commission's website at http://www.sec.gov and also in the Investor Relations section of the website. from GCBC at http://ir.globalcordbloodcorp.com. GCBC will provide a hard copy of the annual report, including a complete set of audited financial statements, free of charge to its shareholders upon request.
About the World Cord Blood Society
The World Cord Blood Society is the first and largest umbilical cord blood bank operator in China in terms of coverage and the only cord blood bank operator with several licenses. Under current government regulations of the People's Republic of China only one licensed cord blood bank operator is allowed to operate in each authorized region and no new licenses will be granted until 2020 in addition to the seven licenses authorized to date. Global Cord Blood Corporation provides cord blood collection, laboratory, hematopoietic stem cell processing and stem cell storage services. For more information, please visit our website at http://www.globalcordbloodcorp.com
For more information, please contact:
Global Cord Blood Corporation
Investor Relations Department
Tel: (+852) 3605-8180
E-mail: [email protected]
ICR, Inc.
M. William Zima
] Phone: (+86) 10-6583-7511
US Phone: (646) 405-5185
Email: [email protected]
Related links:
http: // www.globalcordbloodcorp.com
POST
Buy this article for republication.
Source link
